Greater Lawrence Family Health Center

Comprehensive opioid use disorder treatment and integrated medical care in a Massachusetts community health center serving a predominantly low-income and Hispanic population 

Given a recent infectious disease outbreak among IV drug users, the Greater Lawrence Family Health Center (GLFHC) recognizes that they must treat infectious diseases and opioid use disorder (OUD) simultaneously for maximum efficacy. The community health center is a collection of community-based health care clinics that provide primary care to around 60,000 patients across six sites. Treatment provided is comprehensive with some of the more innovative services including:

  • using an Evidence-to-Intervention grant to implement a mobile buprenorphine program intended for people who inject drugs and also living with HIV, which has shown promising treatment retention rates
  • same-day appointments at the office-based addiction treatment program where primary care, pharmacy services, and support groups are co-located with the clinic
  • started a program called the Bridge, in which a patient admitted to the emergency department can be inducted on OUD treatment and linked back to outpatient services at GLFHC to continue receiving medication
  • all physicians treating chronic infectious diseases (e.g. HIV) are also waivered to prescribe buprenorphine
  • a community-based syringe service program with naloxone distribution 

One feature that allows GLFHC to expand and integrate its services is that nearly all patients have health insurance due to healthcare reform in Massachusetts (98% of patient visits at GLFHC are reimbursed through insurance), so grants and other sources of funding are rarely used for indigent care.

GLFHC was highlighted as a model program in the consensus report here. More information on the program and outcomes can be found here. The community health center is currently part of an innovative intervention to inform and incentivize patients to participate in a medication disposal program by buying back their unused prescription opioids. 

Approximately 500 people are on MOUD and 20 people receive MOUD services through the mobile clinic, with many of these people also receiving infectious disease care. 

Continuum of Care
Prevention
Treatment
Harm Reduction
Type of Evidence
Report with evaluation
Response Approach
Cautious Opioid Prescribing
Comprehensive services
Medications for Opioid Use Disorder
Overdose prevention
Syringe service program / Needle exchange

Evidence of Program Effectiveness

GLFHC has been highlighted in this consensus report, which provides the following evaluation data:

  • Approximately 500 individuals are on MOUD through GLFHC, and about 40 percent of that group is living with HIV or viral hepatitis (or both)
  • It distributes 20,000 syringes per month, naloxone, and education materials
  • GLFHC’s Mobile Health Unit provides MOUD (primarily buprenorphine) for approximately 20 people each week and treatment and care for HIV

More outcome data can be found in this grant report form